Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.64 +0.03 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Operating Expenses (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) posted Operating Expenses of $31.6 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 15.1% from $37.21 million a year earlier but up 8.9% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Operating Expenses (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Enanta Pharmaceuticals was $123.99 million, down 23.3% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $150.67 million, down 20.4% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
  • In prior fiscal years, Enanta Pharmaceuticals' Operating Expenses was $189.33 million in FY2024 (-12.5%), $216.41 million in FY2023 (+3.1%), $210 million in FY2022 (+1.6%) and $206.65 million in FY2021 (+25.9%).
  • Quarterly Operating Expenses has run from a low of $29.01 million in fiscal Q2 2026 to a high of $58.06 million in fiscal Q1 2022 over five years.
  • On a year-over-year basis, Operating Expenses has declined in each of the last 11 quarters, with an average decline of 19.9% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was fiscal Q4 2021, with growth of 32.0%; the weakest was fiscal Q2 2026, with a decline of 26.5%.
  • According to Business Quant data, Operating Expenses for the three prior fiscal quarters was $29.01 million (Q2 2026), $29.87 million (Q1 2026) and $33.51 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Enanta Pharmaceuticals 367.20 Mn -360.79 Mn - 31.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.60 Mn
Mar 31, 2026 29.01 Mn
Dec 31, 2025 29.87 Mn
Sep 30, 2025 33.51 Mn
Jun 30, 2025 37.21 Mn
Mar 31, 2025 39.45 Mn
Dec 31, 2024 40.50 Mn
Sep 30, 2024 44.46 Mn
Jun 30, 2024 42.16 Mn
Mar 31, 2024 49.82 Mn
Dec 31, 2023 52.89 Mn
Sep 30, 2023 49.96 Mn
Jun 30, 2023 55.61 Mn
Mar 31, 2023 57.25 Mn
Dec 31, 2022 53.60 Mn
Sep 30, 2022 47.37 Mn
Jun 30, 2022 52.02 Mn
Mar 31, 2022 52.56 Mn
Dec 31, 2021 58.06 Mn
Sep 30, 2021 57.30 Mn
API Access

Enanta Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ENTA&period=max&api_key=YOUR_API_KEY